Administration of eritoran once daily for 5 consecutive days to wild-type mice starting 2 days after PR8 infection resulted in highly significant protection against lethality and improved lung pathology.
← all excerpts
Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference.
1
—
—